Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference2% 
- Check32 days agoChange DetectedRemoved a specific resource entry (Head and neck squamous cell carcinoma) and updated the page version to v3.1.0.SummaryDifference0.4% 
- Check47 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the only other change is the removal of the Back to Top element, which is a minor UI tweak.SummaryDifference0.1% 
- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1% 
- Check61 days agoChange DetectedThe web page has been updated to include specific resources related to head and neck cancer, including new genetic and rare disease information, while also removing some previously listed locations and terms.SummaryDifference3% 
- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1% 
Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.